Pretreatment with the p38 inhibitor SB203580, increased expression of p-STAT3 in the lung adenocarcinoma cell line A54934 indicating that STAT3 was downstream of the ERK and p38 signaling pathways. Here, STAT3 is linked to lung adenocarcinoma.